Literature DB >> 18313759

Genetic factors involved in the pathogenesis of Parkinson's disease.

Frank J S Lee1, Fang Liu.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disease characterized by a loss of nigrostriatal dopaminergic neurons. Recently, PD research has been stimulated by the identification of genes that are implicated in rare familial forms of PD. However, despite these discoveries, the primary cause of PD is still unclear. Various pathogenic mechanisms may be involved including mitochondrial dysfunction, proteasomal dysfunction/protein aggregation, oxidative damage, environmental factors and genetic disposition. Furthermore, dopamine has also been implicated in contributing to the pathogenesis of PD. This review will focus on the genes that have been identified to be associated with PD and how they may impair dopamine metabolism. Understanding the role of these PD-related genes in dopamine neurobiology may provide insight into the underpinning pathogenic mechanisms of PD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313759     DOI: 10.1016/j.brainresrev.2008.02.001

Source DB:  PubMed          Journal:  Brain Res Rev        ISSN: 0165-0173


  14 in total

1.  The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.

Authors:  Erin K Butler; Aaron Voigt; A Kathrin Lutz; Jane P Toegel; Ellen Gerhardt; Peter Karsten; Björn Falkenburger; Andrea Reinartz; Konstanze F Winklhofer; Jörg B Schulz
Journal:  PLoS Genet       Date:  2012-02-02       Impact factor: 5.917

Review 2.  On the key role played by altered protein conformation in Parkinson's disease.

Authors:  L F Agnati; E Baldelli; N Andreoli; A S Woods; V Vellani; D Marcellino; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-06-05       Impact factor: 3.575

3.  Comparative protein interactomics of neuroglobin and myoglobin.

Authors:  Bryan A Haines; Darcy A Davis; Artem Zykovich; Botao Peng; Rammohan Rao; Sean D Mooney; Kunlin Jin; David A Greenberg
Journal:  J Neurochem       Date:  2012-08-14       Impact factor: 5.372

Review 4.  Therapeutic applications of antibodies in non-infectious neurodegenerative diseases.

Authors:  Pavan K Krishnamurthy; Einar M Sigurdsson
Journal:  N Biotechnol       Date:  2011-04-05       Impact factor: 5.079

Review 5.  Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson's Disease: a Systematic Review.

Authors:  Michele Goulart Dos Santos; Lucia Emanueli Schimith; Corinne André-Miral; Ana Luiza Muccillo-Baisch; Bruno Dutra Arbo; Mariana Appel Hort
Journal:  Neurotox Res       Date:  2022-01-11       Impact factor: 3.911

6.  Cholinergic and Dopaminergic Alterations in Nigrostriatal Neurons Are Involved in Environmental Enrichment Motor Protection in a Mouse Model of Parkinson's Disease.

Authors:  Willyan Franco Hilario; Alice Laschuk Herlinger; Lorena Bianchine Areal; Lívia Silveira de Moraes; Tamara Andrea Alarcon Ferreira; Tassiane Emanuelle Servane Andrade; Cristina Martins-Silva; Rita Gomes Wanderley Pires
Journal:  J Mol Neurosci       Date:  2016-09-22       Impact factor: 3.444

7.  Altered regulation of CD200 receptor in monocyte-derived macrophages from individuals with Parkinson's disease.

Authors:  Xiao-Guang Luo; Ji-Juan Zhang; Chao-Dong Zhang; Rong Liu; Lan Zheng; Xi-Jin Wang; Sheng-Di Chen; Jian-Qing Ding
Journal:  Neurochem Res       Date:  2010-04       Impact factor: 3.996

Review 8.  Manganese-Induced Parkinsonism Is Not Idiopathic Parkinson's Disease: Environmental and Genetic Evidence.

Authors:  Tomás R Guilarte; Kalynda K Gonzales
Journal:  Toxicol Sci       Date:  2015-08       Impact factor: 4.849

Review 9.  CD 4+ T cells in the pathobiology of neurodegenerative disorders.

Authors:  Xiuyan Huang; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2009-05-12       Impact factor: 3.478

Review 10.  Mitochondrial dynamics in Parkinson's disease.

Authors:  Victor S Van Laar; Sarah B Berman
Journal:  Exp Neurol       Date:  2009-03-28       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.